Sign in

CIK 0002040475 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Drugs Made In America Acquisition II Corp.

Sign in to watch
Ticker
DMII
Exchange
Nasdaq
Industry
Blank Checks
FY end
Dec 31
Entity type
operating
Phone
954-870-3104
Business address
420 LEXINGTON AVENUE, SUITE 1402, NEW YORK, NY, 10170

Securities

  • DMII Ordinary Shares Nasdaq
  • DMIIR Right Nasdaq
  • DMIIU Unit Nasdaq
  1. 424B4 Offering Prospectus
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. S-1/A Offering Registration Statement
  6. UPLOAD Other SEC-generated Letter
  7. S-1/A Offering Registration Statement
  8. S-1/A Offering Registration Statement
  9. S-1 Offering Registration Statement
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. UPLOAD Other SEC-generated Letter
  12. UPLOAD Other SEC-generated Letter

Page 1 of 1 · 12 filings